These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 19694548)

  • 1. Human immunodeficiency virus, restriction factors, and interferon.
    Neil S; Bieniasz P
    J Interferon Cytokine Res; 2009 Sep; 29(9):569-80. PubMed ID: 19694548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular defenses against HIV, viral evasion and novel therapeutic approaches.
    Lever RA; Lever AM
    J Formos Med Assoc; 2011 Jun; 110(6):350-62. PubMed ID: 21741003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent Degradation.
    Bennett RP; Salter JD; Smith HC
    Trends Mol Med; 2018 May; 24(5):507-520. PubMed ID: 29609878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV Restriction Factors and Mechanisms of Evasion.
    Malim MH; Bieniasz PD
    Cold Spring Harb Perspect Med; 2012 May; 2(5):a006940. PubMed ID: 22553496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cellular restriction factors that target HIV-1 replication.
    Strebel K; Luban J; Jeang KT
    BMC Med; 2009 Sep; 7():48. PubMed ID: 19758442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.
    Tokarev A; Skasko M; Fitzpatrick K; Guatelli J
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1197-210. PubMed ID: 19929170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors.
    Groom HC; Yap MW; Galão RP; Neil SJ; Bishop KN
    Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5166-71. PubMed ID: 20194752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CBFß and HIV Infection.
    Kim DY; Gross JD
    Adv Exp Med Biol; 2017; 962():415-431. PubMed ID: 28299671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Vif, APOBEC, and intrinsic immunity.
    Goila-Gaur R; Strebel K
    Retrovirology; 2008 Jun; 5():51. PubMed ID: 18577210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of innate immunity in control of mucosal transmission of HIV.
    Wang Y; Lehner T
    Curr Opin HIV AIDS; 2011 Sep; 6(5):398-404. PubMed ID: 21734563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing immunity to HIV through APOBEC.
    Harris RS
    Nat Biotechnol; 2008 Oct; 26(10):1089-90. PubMed ID: 18846074
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesis.
    Williams KC; Burdo TH
    APMIS; 2009 May; 117(5-6):400-12. PubMed ID: 19400864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.
    Dang Y; Wang X; York IA; Zheng YH
    J Virol; 2010 Sep; 84(17):8561-70. PubMed ID: 20592083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors.
    Binning JM; Smith AM; Hultquist JF; Craik CS; Caretta Cartozo N; Campbell MG; Burton L; La Greca F; McGregor MJ; Ta HM; Bartholomeeusen K; Peterlin BM; Krogan NJ; Sevillano N; Cheng Y; Gross JD
    PLoS Pathog; 2018 Jan; 14(1):e1006830. PubMed ID: 29304101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule inhibition of HIV-1 Vif.
    Nathans R; Cao H; Sharova N; Ali A; Sharkey M; Stranska R; Stevenson M; Rana TM
    Nat Biotechnol; 2008 Oct; 26(10):1187-92. PubMed ID: 18806783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic cellular defenses against human immunodeficiency viruses.
    Blanco-Melo D; Venkatesh S; Bieniasz PD
    Immunity; 2012 Sep; 37(3):399-411. PubMed ID: 22999946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells.
    Sakuma R; Mael AA; Ikeda Y
    J Virol; 2007 Sep; 81(18):10201-6. PubMed ID: 17609277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between HIV-1 and APOBEC3 sub-family of proteins.
    Arriaga ME; Carr J; Li P; Wang B; Saksena NK
    Curr HIV Res; 2006 Oct; 4(4):401-9. PubMed ID: 17073615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1.
    Colomer-Lluch M; Ruiz A; Moris A; Prado JG
    Front Immunol; 2018; 9():2876. PubMed ID: 30574147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-guided analysis of the human APOBEC3-HIV restrictome.
    Aydin H; Taylor MW; Lee JE
    Structure; 2014 May; 22(5):668-84. PubMed ID: 24657093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.